カテゴリー： IMARC, 世界, 医療/バイオ

世界の日光角化症治療市場予測2021年-2026年

【英語タイトル】Actinic Keratosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

IMARCが出版した調査資料（IMA22FB466）・商品コード：IMA22FB466
・発行会社（調査会社）：IMARC
・発行日：2021年12月10日
・ページ数：143
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,299 ⇒換算￥298,870見積依頼/購入/質問フォーム
Five UserUSD3,399 ⇒換算￥441,870見積依頼/購入/質問フォーム
EnterprisewideUSD0 ⇒換算￥0見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
本市場調査レポートでは、世界の日光角化症治療市場について調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（処方、OTC）分析、医薬品種類別（フルオロウラシル、イミキモド、ジクロフェナク、その他）分析、流通チャネル別（病院薬局、ドラッグストア・小売薬局、オンラインストア）分析、地域別分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の日光角化症治療市場規模：種類別（処方、OTC）
・世界の日光角化症治療市場規模：医薬品種類別（フルオロウラシル、イミキモド、ジクロフェナク、その他）
・世界の日光角化症治療市場規模：流通チャネル別（病院薬局、ドラッグストア・小売薬局、オンラインストア）
・世界の日光角化症治療市場規模：地域別
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況
❖ レポートの概要 ❖

The global actinic keratosis treatment market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 5% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Actinic keratosis, also known as solar keratosis, refers to a skin condition that develops on the sun-exposed areas of the body. It causes rough, scaly patches to appear on the hands, arms, lips, scalp, and other body parts that can further develop into a skin cancer called squamous cell carcinoma. Some of the commonly used treatments to remove actinic keratosis include cryotherapy, curettage, laser therapy, and photodynamic therapy. At present, the considerably expanding healthcare infrastructure and increasing need for preventive strategies for cancer are positively influencing the demand for actinic keratosis treatment worldwide.

Actinic Keratosis Treatment Market Trends:
The increasing prevalence of actinic keratosis due to ozone layer depletion and excessive sun exposure represents one of the key factors fueling the growth of the market. Additionally, the rising incidences of cancer, coupled with the escalating demand for minimally invasive (MI) procedures, is strengthening the market growth. Furthermore, leading manufacturers are introducing medications for the treatment of actinic keratosis in the form of cream and gel, which is impelling the market growth. Apart from this, numerous public and private groups are focusing on conducting campaigns to generate awareness about available treatments for actinic keratosis across the globe. This, along with significant investments in the research and development (R&D) activities to develop novel therapies with improved efficacy, convenient dosage, and reduced costs, is creating a favorable market outlook. The market is also driven by the introduction of topical treatment that reduces the risk of scarring. This treatment is also used for treating a wide area of visible and invisible lesions on the skin. Besides this, favorable reimbursement policies are anticipated to fuel the market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global actinic keratosis treatment market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on type, drug type and distribution channel.

Breakup by Type:

Prescription
OTC

Breakup by Drug Type:

Fluorouracil
Imiquimod
Diclofenac
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Stores

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Almirall SA, Bausch Health Companies Inc., Biofrontera Inc., BioLineRx Ltd., Cipher Pharmaceuticals Inc, Galderma SA, Hill Dermaceuticals Inc., LEO Pharma A/S and Sun Pharmaceutical Industries Ltd.

Key Questions Answered in This Report:
How has the global actinic keratosis treatment market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global actinic keratosis treatment market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the drug type?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global actinic keratosis treatment market and who are the key players?
What is the degree of competition in the industry?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Actinic Keratosis Treatment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Type
6.1 Prescription
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 OTC
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Fluorouracil
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Imiquimod
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Diclofenac
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Stores and Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Online Stores
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 3M Company
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Almirall SA
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bausch Health Companies Inc.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Biofrontera Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 BioLineRx Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.6 Cipher Pharmaceuticals Inc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.7 Galderma SA
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 SWOT Analysis
14.3.8 Hill Dermaceuticals Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 LEO Pharma A/S
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Sun Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis

Figure 1: Global: Actinic Keratosis Treatment Market: Major Drivers and Challenges
Figure 2: Global: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Actinic Keratosis Treatment Market: Breakup by Type (in %), 2020
Figure 5: Global: Actinic Keratosis Treatment Market: Breakup by Drug Type (in %), 2020
Figure 6: Global: Actinic Keratosis Treatment Market: Breakup by Distribution Channel (in %), 2020
Figure 7: Global: Actinic Keratosis Treatment Market: Breakup by Region (in %), 2020
Figure 8: Global: Actinic Keratosis Treatment (Prescription) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Actinic Keratosis Treatment (Prescription) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Actinic Keratosis Treatment (OTC) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Actinic Keratosis Treatment (OTC) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Actinic Keratosis Treatment (Fluorouracil) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Actinic Keratosis Treatment (Fluorouracil) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Actinic Keratosis Treatment (Imiquimod) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Actinic Keratosis Treatment (Imiquimod) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Actinic Keratosis Treatment (Diclofenac) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Actinic Keratosis Treatment (Diclofenac) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Actinic Keratosis Treatment (Other Drug Types) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Actinic Keratosis Treatment (Other Drug Types) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Actinic Keratosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Actinic Keratosis Treatment (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Actinic Keratosis Treatment (Online Stores) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Actinic Keratosis Treatment (Online Stores) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: North America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: North America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: United States: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: United States: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Canada: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Canada: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Asia-Pacific: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Asia-Pacific: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: China: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: China: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Japan: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Japan: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: India: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: India: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: South Korea: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: South Korea: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Australia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Australia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Indonesia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Indonesia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Europe: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Europe: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Germany: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Germany: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: France: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: France: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: United Kingdom: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: United Kingdom: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Italy: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Italy: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Spain: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Spain: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Russia: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Russia: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Latin America: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Latin America: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Brazil: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Brazil: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Mexico: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Mexico: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Others: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Others: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Middle East and Africa: Actinic Keratosis Treatment Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Middle East and Africa: Actinic Keratosis Treatment Market: Breakup by Country (in %), 2020
Figure 74: Middle East and Africa: Actinic Keratosis Treatment Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Global: Actinic Keratosis Treatment Industry: SWOT Analysis
Figure 76: Global: Actinic Keratosis Treatment Industry: Value Chain Analysis
Figure 77: Global: Actinic Keratosis Treatment Industry: Porter's Five Forces Analysis

Table 1: Global: Actinic Keratosis Treatment Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Type (in Million US$), 2021-2026
Table 3: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2021-2026
Table 4: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 5: Global: Actinic Keratosis Treatment Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Actinic Keratosis Treatment Market: Competitive Structure
Table 7: Global: Actinic Keratosis Treatment Market: Key Players

★調査レポート[世界の日光角化症治療市場予測2021年-2026年] (コード：IMA22FB466)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の日光角化症治療市場予測2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の消化管治療市場予測2021年-2026年
    IMA22FB885 / IMARC / 2021年11月10日 / 本市場調査レポートでは、世界の消化管治療市場について調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（ブランド、ジェネリック）分析、投与経路別（経口、静脈内、その他）分析、用途別（潰瘍性大腸炎、クローン病、GERD、その他）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション...
  • 世界の乾癬性関節炎治療市場予測2021年-2026年
    IMA22FB271 / IMARC / 2021年12月10日 / 本調査レポートでは、世界の乾癬性関節炎治療市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、医薬品別（NSAID（非ステロイド性抗炎症薬）、DMARD（疾患修飾性抗リウマチ薬）、生物製剤、その他）分析、種類別（処方、OTC）分析、投与経路別（注射、経口、局所）分析、流通チャンネル別（病院薬局、小売薬局、オンライン薬局）分析、地域別分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格指標、競争状況などの項目を掲載しています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション...
  • 世界の多発性骨髄腫治療薬市場予測2021年-2026年
    IMA21SE200 / IMARC / 2021年8月 / 本書では、多発性骨髄腫治療薬の世界市場を調査対象とし、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、治療別（標的治療、生物学的治療、化学治療、その他）分析、薬剤種類別（免疫調節薬、プロテアソーム阻害剤、ヒストンデアセチラーゼ阻害剤、モノクローナル抗体薬、ステロイド）分析、エンドユーザー別（男性、女性）分析、流通チャネル別（病院薬局、小売薬局、オンライン薬局、その他）分析、地域別分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格指標、競争状況などを整理しました。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション...
  • 世界の脱毛症治療市場予測2021年-2026年
    IMA22FB509 / IMARC / 2021年12月10日 / 本市場調査レポートでは、世界の脱毛症治療市場について調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、医薬品種類別（ミノキシジル、フィナステリド、その他）分析、疾患別（アンドロゲン性脱毛症、円形脱毛症、全頭脱毛症、その他）分析、性別（男性、女性）分析、投与経路別（経口、局所、注射可能）分析、地域別分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション...
  • 世界の抗リウマチ薬市場予測2021年-2026年
    IMA22FB528 / IMARC / 2021年12月10日 / 本市場調査レポートでは、世界の抗リウマチ薬市場について調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、種類別（処方薬、市販薬）分析、医薬品クラス別（疾患修飾性抗リウマチ薬（DMARD）、非ステロイド性抗炎症薬（NSAID）、コルチコステロイド、尿酸薬、その他）分析、医薬品投与経路別（経口、非経口、その他）分析、流通チャネル別（病院薬局、小売薬局、Eコマース）分析、地域別分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション...

    • ◆H&Iグローバルリサーチのお客様（例）◆